Quantification of myocardial amyloid deposition in tafamidis-treated patients with transthyretin amyloid cardiomyopathy

被引：0

作者：

Rettl, R. ^{[1
]}

Wollenweber, T. ^{[1
]}

Mann, C. ^{[1
]}

Duca, F. ^{[1
]}

Dachs, T. -M. ^{[1
]}

Binder, C. ^{[1
]}

Stojanovic, M. ^{[1
]}

Ligios, L. Camuz ^{[1
]}

Schrutka, L. ^{[1
]}

Dalos, D. ^{[1
]}

Charwat-Resl, S. ^{[2
]}

Eslam, R. Badr ^{[1
]}

Kastner, J. ^{[1
]}

Hacker, M. ^{[1
]}

Bonderman, D. ^{[2
]}

机构：

[1] Med Univ Vienna, Vienna, Austria

[2] Clin Favoriten, Vienna, Austria

来源：

EUROPEAN HEART JOURNAL | 2021年 / 42卷

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：1811 / 1811

页数：1

共 50 条

[1] Effects of tafamidis on quantification of myocardial amyloid deposits in patients with transthyretin amyloid cardiomyopathy
Rettl, R.
Wollenweber, T.
Mann, C.
Duca, F.
Dachs, T.
Binder, C.
Stojanovic, M.
Ligios, L. Camuz
Schrutka, L.
Dalos, D.
Charwat-Resl, S.
Hengstenberg, C.
Eslam, R. Badr
Kastner, J.
Hacker, M.
Bonderman, D.
[J]. WIENER KLINISCHE WOCHENSCHRIFT, 2021, 133 (SUPPL 3) : S105 - S106
[2] Effects of tafamidis on quantification of myocardial amyloid deposits in patients with transthyretin amyloid cardiomyopathy
Rettl, R. Rene
Wollenweber, T.
Mann, C.
Duca, F.
Dachs, T-M
Binder, C.
Stojanovic, M.
Ligios, L. Camuz
Schrutka, L.
Dalos, D.
Charwat-Resl, S.
Eslam, R. Badr
Kastner, J.
Hacker, M.
Bonderman, D.
[J]. EUROPEAN JOURNAL OF HEART FAILURE, 2021, 23 : 253 - 253
[3] Effects of tafamidis on exercise capacity, cardiac function and myocardial amyloid deposition in patients with transthyretin amyloid cardiomyopathy
Rettl, R.
Christopher, M.
Dachs, T.
Duca, F.
Binder, C.
Dusik, F.
Seirer, B.
Eslam, R. Badr
Hengstenberg, C.
Bonderman, D.
[J]. WIENER KLINISCHE WOCHENSCHRIFT, 2020, 132 : S285 - S286
[4] Effects of tafamidis on exercise capacity, cardiac function and myocardial amyloid deposition in patients with transthyretin amyloid cardiomyopathy
Rettl, R.
Mann, C.
Dachs, T.
Duca, F.
Binder, C.
Dusik, F.
Seirer, B.
Eslam, R. Badr
Hengstenberg, C.
Bonderman, D.
[J]. EUROPEAN HEART JOURNAL, 2020, 41 : 1029 - 1029
[5] Effects of tafamidis on exercise capacity, cardiac function and myocardial amyloid deposition in patients with transthyretin amyloid cardiomyopathy
Rettl, R. Rene
Duca, F.
Binder, C.
Capelle, C.
Eslam, R. Badr
Aschauer, S.
Mascherbauer, J.
Hengstenberg, C.
Bonderman, D.
[J]. EUROPEAN JOURNAL OF HEART FAILURE, 2020, 22 : 8 - 8
[6] Relationship of binding-site occupancy, transthyretin stabilisation and disease modification in patients with tafamidis-treated transthyretin amyloid cardiomyopathy
Tess, David. A. A.
Maurer, Tristan. S. S.
Li, Zhenhong
Bulawa, Christine
Fleming, James
Moody, Amy. T. T.
[J]. AMYLOID-JOURNAL OF PROTEIN FOLDING DISORDERS, 2023, 30 (02): : 208 - 219
[7] Outcomes of Octogenarian Patients Treated with Tafamidis for Transthyretin Amyloid Cardiomyopathy
Sarkar, Abdullah
Sanchez-Nadales, Alejandro
Kunutsor, Setor K.
Hanna, Mazen A.
Asher, Craig R.
Wolinsky, David G.
[J]. AMERICAN JOURNAL OF CARDIOLOGY, 2024, 214 : 144 - 148
[8] Tafamidis for Transthyretin Amyloid Cardiomyopathy
不详
[J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 2018, 104 (05) : 773 - 773
[9] Tafamidis for Transthyretin Amyloid Cardiomyopathy
Manion, Christopher
Sharma, Umesh C.
Rapezzi, Claudio
[J]. NEW ENGLAND JOURNAL OF MEDICINE, 2019, 380 (02): : 196 - 196
[10] Impact of tafamidis on myocardial strain in transthyretin amyloid cardiomyopathy
Rettl, Rene
Duca, Franz
Binder, Christina
Dachs, Theresa-Marie
Cherouny, Bernhard
Ligios, Luciana Camuz
Mann, Christopher
Schrutka, Lore
Dalos, Daniel
Charwat-Resl, Silvia
Eslam, Roza Badr
Kastner, Johannes
Bonderman, Diana
[J]. AMYLOID-JOURNAL OF PROTEIN FOLDING DISORDERS, 2023, 30 (01): : 127 - 137

← 1 2 3 4 5 →